Clinical Trial Update: Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Early-stage trial updating on combining stereotactic body radiotherapy with cadonilimab for advanced solid tumors, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Peking University Third Hospital | Conditions: Advanced Solid Tumor, Stereotactic Body Radiotherapy | Phase 1, Phase 2 | Status: UNKNOWN